Your browser doesn't support javascript.
loading
Combinatorial Inactivation of Tumor Suppressors Efficiently Initiates Lung Adenocarcinoma with Therapeutic Vulnerabilities.
Yousefi, Maryam; Boross, Gábor; Weiss, Carly; Murray, Christopher W; Hebert, Jess D; Cai, Hongchen; Ashkin, Emily L; Karmakar, Saswati; Andrejka, Laura; Chen, Leo; Wang, Minwei; Tsai, Min K; Lin, Wen-Yang; Li, Chuan; Yakhchalian, Pegah; Colón, Caterina I; Chew, Su-Kit; Chu, Pauline; Swanton, Charles; Kunder, Christian A; Petrov, Dmitri A; Winslow, Monte M.
Afiliación
  • Yousefi M; Department of Genetics, Stanford University School of Medicine, Stanford, California.
  • Boross G; Department of Biology, Stanford University, Stanford, California.
  • Weiss C; Department of Biology, Stanford University, Stanford, California.
  • Murray CW; Cancer Biology Program, Stanford University School of Medicine, Stanford, California.
  • Hebert JD; Department of Genetics, Stanford University School of Medicine, Stanford, California.
  • Cai H; Department of Genetics, Stanford University School of Medicine, Stanford, California.
  • Ashkin EL; Cancer Biology Program, Stanford University School of Medicine, Stanford, California.
  • Karmakar S; Department of Genetics, Stanford University School of Medicine, Stanford, California.
  • Andrejka L; Department of Genetics, Stanford University School of Medicine, Stanford, California.
  • Chen L; Department of Genetics, Stanford University School of Medicine, Stanford, California.
  • Wang M; Department of Genetics, Stanford University School of Medicine, Stanford, California.
  • Tsai MK; Department of Genetics, Stanford University School of Medicine, Stanford, California.
  • Lin WY; Department of Genetics, Stanford University School of Medicine, Stanford, California.
  • Li C; Department of Biology, Stanford University, Stanford, California.
  • Yakhchalian P; Department of Medicine, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, California.
  • Colón CI; Cancer Biology Program, Stanford University School of Medicine, Stanford, California.
  • Chew SK; Cancer Evolution and Genome Instability Laboratory, University College London Cancer Institute, London, United Kingdom.
  • Chu P; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, United Kingdom.
  • Swanton C; Department of Pathology, Stanford University School of Medicine, Stanford, California.
  • Kunder CA; Cancer Evolution and Genome Instability Laboratory, University College London Cancer Institute, London, United Kingdom.
  • Petrov DA; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, United Kingdom.
  • Winslow MM; Department of Pathology, Stanford University School of Medicine, Stanford, California.
Cancer Res ; 82(8): 1589-1602, 2022 04 15.
Article en En | MEDLINE | ID: mdl-35425962
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Adenocarcinoma del Pulmón / Neoplasias Pulmonares Límite: Animals / Humans Idioma: En Revista: Cancer Res Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Adenocarcinoma del Pulmón / Neoplasias Pulmonares Límite: Animals / Humans Idioma: En Revista: Cancer Res Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos